Leticia Sarasa

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

Shorena Janelidze, Charlotte E. Teunissen, Henrik Zetterberg et al. · JAMA Neurology · 2021 · 474 citations · Full text

Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau

Shorena Janelidze, Sebastian Palmqvist, Antoine Leuzy et al. · Alzheimer s & Dementia · 2021 · 193 citations · Full text

Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations

Nicholas Cullen, Antoine Leuzy, Sebastian Palmqvist et al. · Nature Aging · 2020 · 189 citations

Alzheimer's Disease, Plasma Biomarker Combinations, Medicine +10

Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study

Virginia Pérez‐Grijalba, Judith Romero, Pedro Pesini et al. · The Journal of Prevention of Alzheimer s Disease · 2019 · 117 citations · Full text

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial

Ana-María Lacosta, María Pascual‐Lucas, Pedro Pesini et al. · Alzheimer s Research & Therapy · 2018 · 106 citations · Full text